Skip to main content
AVAHAveanna Healthcare Holdings IncHold6.0·$9.15+3.27%
AVAH · Concentration risk · 10-K extracted

Aveanna Healthcare Holdings (AVAH) concentration risks

Updated

The most significant concentration Aveanna Healthcare Holdings discloses is Medicare, Medicaid and private health insurance payers, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Aveanna Healthcare Holdings’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH1
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inCustomer

Medicare, Medicaid and private health insurance payers

10-K Item 1A: 'Third-party payers including Medicare, Medicaid and private health insurance payers provide substantially all funding for our home health and hospice services'
SEC 10-K · filed Mar 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-06

Aveanna Healthcare's disclosed concentration risk is payer-based and structural: third-party payers, including Medicare, Medicaid, and private health insurance payers, provide substantially all funding for the company's home health and hospice services. This is a high-size, structural exposure — the risk is embedded in the fundamental economics of the home health and hospice industry, where reimbursement from government and private insurance programs is the near-universal funding mechanism, rather than being tied to any single counterparty relationship that could be renegotiated or replaced. Because Medicare, Medicaid, and private insurers together provide substantially all funding, Aveanna's results are directly sensitive to reimbursement rate changes, policy shifts, or coverage rule changes affecting any of these payer categories, with essentially no alternative revenue base to fall back on. With this as the only disclosed concentration exposure and its size at the high end of the scale, payer-mix and reimbursement policy risk is the single most important factor shaping Aveanna's outlook — an investor should treat regulatory and reimbursement developments across Medicare, Medicaid, and private insurance as the primary lens for evaluating this name's durability.

For the engine’s reasoning on AVAH’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Care Facilities

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ACHCAcadia Healthcare Company, Inc.1102
AVAHAveanna Healthcare Holdings Inc1001
ADUSAddus HomeCare Corporation0246
ARDTArdent Health, Inc.0202
AMNAMN Healthcare Services Inc0011
AGLagilon health, inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks AVAH Concentration risk